Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
Saved in:
| Title: | Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile. |
|---|---|
| Authors: | Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Prager-van der Smissen WJC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Ruigrok-Ritstier K; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Schreurs MAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Cornelissen S; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Garcia AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Broeks A; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Timmermans AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Trapman-Jansen AMAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Collée JM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands., Adank MA; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. a.hollestelle@erasmusmc.nl. |
| Source: | Breast cancer research : BCR [Breast Cancer Res] 2023 May 09; Vol. 25 (1), pp. 53. Date of Electronic Publication: 2023 May 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37161532 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Smid+M%22">Smid M</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schmidt+MK%22">Schmidt MK</searchLink>; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Prager-van+der+Smissen+WJC%22">Prager-van der Smissen WJC</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ruigrok-Ritstier+K%22">Ruigrok-Ritstier K</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schreurs+MAC%22">Schreurs MAC</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cornelissen+S%22">Cornelissen S</searchLink>; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Garcia+AM%22">Garcia AM</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Broeks+A%22">Broeks A</searchLink>; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Timmermans+AM%22">Timmermans AM</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Trapman-Jansen+AMAC%22">Trapman-Jansen AMAC</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Collée+JM%22">Collée JM</searchLink>; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Adank+MA%22">Adank MA</searchLink>; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hooning+MJ%22">Hooning MJ</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Martens+JWM%22">Martens JWM</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hollestelle+A%22">Hollestelle A</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. a.hollestelle@erasmusmc.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100927353%22">Breast cancer research : BCR</searchLink> [Breast Cancer Res] 2023 May 09; Vol. 25 (1), pp. 53. <i>Date of Electronic Publication: </i>2023 May 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100927353 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-542X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214655411%22">14655411 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37161532 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13058-023-01653-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 53 Titles: – TitleFull: Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Smid M – PersonEntity: Name: NameFull: Schmidt MK – PersonEntity: Name: NameFull: Prager-van der Smissen WJC – PersonEntity: Name: NameFull: Ruigrok-Ritstier K – PersonEntity: Name: NameFull: Schreurs MAC – PersonEntity: Name: NameFull: Cornelissen S – PersonEntity: Name: NameFull: Garcia AM – PersonEntity: Name: NameFull: Broeks A – PersonEntity: Name: NameFull: Timmermans AM – PersonEntity: Name: NameFull: Trapman-Jansen AMAC – PersonEntity: Name: NameFull: Collée JM – PersonEntity: Name: NameFull: Adank MA – PersonEntity: Name: NameFull: Hooning MJ – PersonEntity: Name: NameFull: Martens JWM – PersonEntity: Name: NameFull: Hollestelle A IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 05 Text: 2023 May 09 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1465-542X Numbering: – Type: volume Value: 25 – Type: issue Value: 1 Titles: – TitleFull: Breast cancer research : BCR Type: main |
| ResultId | 1 |